Condition: Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) · Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
TQC2731 injection is a humanized monoclonal antibody that targets Thymic Stromal Lymphopoietin (TSLP), blocks the TSLP pathway, and inhibits the production of downstream cytokines, thereby exerting anti-inflammatory effects. The purpose of this study is to evaluate the efficacy and safety of TQC2731 injection in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
This description comes directly from the study's public registry record.
Dehui Wang, Doctor · 13701852008 · wangdehuient@sina.com
Always discuss trial participation with your own doctor first.
| Zhongda Hosiptal Southeast University | Fuyang, Anhui, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Anhui Medical University | Hefei, Anhui, China | Not Yet Recruiting |
| Peking University People'S Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Beijing youan hospital，capital medical university | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| The First Affiliated Hospital of Xiamen University | Xiamen, Fujian, China | Not Yet Recruiting |
| The 940th Hospital of Joint Logistics Support force of Chinese People 's Liberation Army | Lanzhou, Gansu, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Guangzhou Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Shenzhen Second People'S Hospital | Shenzhen, Guangdong, China | Not Yet Recruiting |
| Liuzhou People's Hospital | Liuzhou, Guangxi, China | Not Yet Recruiting |
| Cangzhou Central Hospital | Cangzhou, Hebei, China | Not Yet Recruiting |
| Hebei Petro China Central Hospital | Langfang, Hebei, China | Not Yet Recruiting |
+ 48 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07107256